<DOC>
	<DOCNO>NCT02030925</DOCNO>
	<brief_summary>This study mean assess effect IW-3718 add treatment ongoing once-daily protocol pump inhibitor ( PPI ) treatment patient continue experience symptom gastroesophageal reflux disease ( GERD ) .</brief_summary>
	<brief_title>Ph2a Study Evaluate IW-3718 Patients With Gastroesophageal Reflux Not Completely Responsive Proton Pump Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Patient 18 65 year age Screening Visit ; female must pregnant must breastfeed ; Patient confirm diagnosis gastroesophageal reflux disease , must currently take proton pump inhibitor ( PPI ) , must experience GERD symptom specify protocol . Patient may meet excluded condition specify protocol ; Patient experience alarm symptom GI bleeding , anemia , vomit , dysphagia , unexpected weight loss ; Patient clinically significant hypersensitivity allergy active ingredient excipients study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>